Clinical Trials for Drug: Marizomib

2 Open Trials. Phone:(877.827.8839)
Protocol No. Title Status
UCI-14-58 Phase I, Multi-Center, Open-Label, Dose-Escalation, Combination Study of Marizomib and Bevacizumab in Bevacizumab-Naïve Subjects with WHO Grade IV Malignant Glioma Followed by Phase II Studies of Single Agent Marizomib and Combination Marizomib and Bevacizumab, and Phase I Dose-Escalation Study of Enternally-Administered Marizomib with Bevacizumab Open
UCI-16-55 Phase Ib, Multicenter, Open-Label Study of Marizomib with Temozolomide and Radiotherapy in Patients with Newly Diagnosed WHO Grade IV Malignant Glioma Open